CluePoints Senior Vice President, Europe, and APAC, to Speak at SCOPE 2022
John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful decentralized trials at this year’s SCOPE Conference, a Summit for Clinical Ops Executives. Delivering Successful Decentralized Trials – How RBQM and Centralized Monitoring can Maximize Data Quality will occur at 12:30 pm on February 8, 2022. The shift to decentralized research […]
HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China
King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has collaborated with CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to provide Risk-Based Quality Management (RBQM) expertise and technology in the Chinese region. This market-leading partnership will increase clinical trial efficiency and reduce deviation and […]
CluePoints Wins Scrip Award for Clinical Advance of the Year 2021
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category – COVID-19 Pandemic Special Recognition Award at the 17th Annual Scrip Awards. The 2021 Scrip Awards was held at the Royal Lancaster Hotel, London, […]
CluePoints Chief Scientific Officer to Speak at CNS Summit Next Month
Steve Young, Chief Scientific Officer at CluePoints, will take to the podium at this year’s CNS Summit with Lynne Cesario, Global Risk-Based Monitoring Program Lead at Pfizer. The Patients are Waiting – Reducing 10 Years of Development to Less Than 10 Months takes place on the second day of the summit (Monday, November 8). Held from […]
CluePoints SVP of Business Development to Speak at Clinical Trials Europe
John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated with Decentralized Clinical Trials (DCTs) at Clinical Trials Europe. The Dimensions of Risk Associated with DCT’s is a Spotlight Session on day 2 of the virtual summit. From 1.35 pm on 3 November, John will share his expertise on the […]
CluePoints Shortlisted for Multiple Awards in Recognition of Pioneering Risk-Based Quality Management Solution
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for three international awards. CluePoints, BioNTech, and Pfizer’s Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty) has been selected as a finalist for the Clinical Advance of the Year – […]
CluePoints Chief Scientific Officer And Pfizer’s Global RBM Program Lead To Speak At #CQOF2021
Join us at #CQOF2021! As well as hosting a booth at the Clinical Quality Oversight Forum where visitors will be able to learn about our industry-leading Risk-Based Quality Management (RBQM) platform, CluePoints will deliver a co-presentation with Pfizer. Our Chief Scientific Officer, Steve Young will take to the podium with Pfizer’s Risk-Based Monitoring Program Lead, […]
Will ICH E6 (R3) Unleash The Potential Of Risk-Based Trials?
Researchers have been slow to fully adopt innovations designed to overcome the challenges to modern day clinical research, in no small part due to a lack of clarity around their Good Clinical Practice (GCP) use. But an imminent update to the International Harmonization Council’s (ICH) guidelines could be about to change all that and in […]
CluePoints Partners With ZS To Provide Best-In-Class RBQM Expertise And Technology, Increasing Clinical Trial Efficiency And Improving Patient Outcomes
CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS, a global professional services firm with technology and analytics expertise in biopharma, to offer innovative capabilities in portfolio-level performance oversight. The new partnership pairs a best-in-breed solutions company focused on study-level risk-based management with a pharmaceutical and biotech solutions provider with advanced […]
Introducing CluePoints’ Post-COVID Trial Assurance Solution
For well over a year now, the clinical research community has been hard at work to maintain progress in developing new treatments and therapies to improve, protect, extend, and save lives. For many sponsors and CROs, the pandemic has been the catalyst for reassessing pre-existing monitoring protocols to ensure that studies stay on track, particularly […]
